Back
Corcept Therapeutics Stock Predictions
Sponsored
CORT
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
CORT
Corcept Therapeutics
Last Price:
42.26
Seasonality Move:
-0.77%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Corcept Therapeutics Stock Forecast
- Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 28.4% based on the past 20 years of stock performance.
- Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
-
Is Corcept Therapeutics Stock Undervalued?
The current Corcept Therapeutics [CORT] share price is $42.28. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal. - CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 28.4% based on the past 20 years of stock performance.
Corcept Therapeutics Stock Rating
Buy
68
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics overpriced?
- Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
Corcept Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
43.74
52-Week Low:
20.84
Prediction Charts
Market Cap:
4.42B
Price in USD:
42.28
Volume:
1.07M
Beta:
0.85
Technical Analysis
SMA50:
35.31
SMA100:
32.38
SMA200:
28.59
52-Wk Change:
31.96%
Stock Predictions
-
Is Corcept Therapeutics stock public?
Yes, Corcept Therapeutics is a publicly traded company. -
What is the Corcept Therapeutics stock quote today?
The Corcept Therapeutics stock price is 42.28 USD today. -
How to buy Corcept Therapeutics stock online?
You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-3 | 35.06 | 34.27 | 35.54 | 34.11 |
Sep-4 | 34.13 | 34.62 | 34.66 | 33.34 |
Sep-5 | 34.74 | 34.07 | 35.58 | 33.85 |
Sep-6 | 34.33 | 34.38 | 34.61 | 33.66 |
Sep-9 | 34.38 | 34.71 | 35.08 | 34.25 |
Sep-10 | 34.84 | 35.03 | 35.04 | 34.34 |
Sep-11 | 35.04 | 35.55 | 36.13 | 34.87 |
Sep-12 | 35.94 | 35.70 | 36.17 | 35.45 |
Sep-13 | 35.94 | 38.11 | 38.18 | 35.87 |
Sep-16 | 38.31 | 38.47 | 39.24 | 37.82 |
Sep-17 | 39.03 | 39.71 | 41.95 | 38.68 |
Sep-18 | 40.30 | 42.27 | 43.32 | 40.15 |
Sep-19 | 43.20 | 40.92 | 43.74 | 40.76 |
Sep-20 | 41.06 | 42.28 | 42.77 | 40.62 |
Corcept Therapeutics Earnings
Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics Forecast Revenue Growth
Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.